Associate Medical Director, Oncology (Genitourinary Focus)

United StatesRemote

Responsibilities

Lead the design and implementation of clinical studies and treatment protocols that integrate Natera’s
Recruit and engage leading principal investigators (PIs) and clinical sites in GU oncology to participate
Advise on product development for the GU oncology portfolio, identifying clinical unmet needs, new
Lead medical education initiatives, including external training, launch planning, and the creation of
Identify and recruit Key Opinion Leaders (KOLs) in GU oncology to serve on advisory boards and contribute to strategic planning.
Support the publication strategy by collaborating with Scientific Communications on manuscripts,
Represent Natera’s medical voice externally through public relations, industry panels, advisory boards,

oversight of a Senior Medical Director, will contribute to an evolving understanding of cancer biology
disease (MRD) and ctDNA-based monitoring.
M.D. required (board-certified or board-eligible in Radiation Oncology preferred)
Residency training in Radiation Oncology
experience in GU cancers (prostate, bladder, kidney, etc.) as a
Deep knowledge of treatment paradigms, clinical guidelines, and diagnostic workflows in GU cancers
experience in academic, biotech, or pharmaceutical settings
Expertise in clinical trial design, regulatory/compliance frameworks, and biostatistics
Strong understanding of evolving treatment landscapes in GU cancers (including targeted therapies,
immunotherapy, and biomarker-driven approaches)
Quick learner with the ability to critically assess Natera’s technology and competing platforms
Proven ability to lead and collaborate across cross-functional teams
Experience with ctDNA, MRD, or liquid biopsy technologies
Experience supporting product launches or diagnostic adoption in oncology Summary
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health.